Powell Investment Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.61K Hold
40
﹤0.01% 161
2026
Q1
$6.75K Hold
40
﹤0.01% 171
2025
Q4
$6.75K Hold
40
﹤0.01% 166
2025
Q3
$5.78K Hold
40
﹤0.01% 165
2025
Q2
$5.06K Hold
40
﹤0.01% 165
2025
Q1
$5.12K Hold
40
﹤0.01% 145
2024
Q4
$5.29K Hold
40
﹤0.01% 154
2024
Q3
$5.82K Hold
40
﹤0.01% 149
2024
Q2
$5.49K Hold
40
﹤0.01% 150
2024
Q1
$5.49K Hold
40
﹤0.01% 145
2023
Q4
$5.43K Hold
40
﹤0.01% 146
2023
Q3
$4.9K Hold
40
﹤0.01% 138
2023
Q2
$5.08K Hold
40
﹤0.01% 132
2023
Q1
$5.17K Hold
40
﹤0.01% 134
2022
Q4
$5.25K Hold
40
﹤0.01% 127
2022
Q3
$5K Hold
40
﹤0.01% 127
2022
Q2
$5K Hold
40
﹤0.01% 140
2022
Q1
$5K Hold
40
﹤0.01% 126
2021
Q4
$6K Hold
40
﹤0.01% 131
2021
Q3
$6K Buy
+40
New +$6.73K ﹤0.01% 123

Other funds holding IBB

Powell Investment Advisors's IBB Position: Q2 2026 in Review

Powell Investment Advisors held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 40 shares worth $7.61K. The position accounts for ﹤0.01% of the portfolio, ranked #161.

Powell Investment Advisors first reported a position in IBB in Q3 2021 and has held it in 20 quarters since. 601 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Powell Investment Advisors held 40 shares of iShares Biotechnology ETF worth $7.61K as of Q2 2026.
  • Powell Investment Advisors left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up ﹤0.01% of Powell Investment Advisors's portfolio in Q2 2026, its #161 holding.
  • Powell Investment Advisors first reported a position in iShares Biotechnology ETF in Q3 2021 and has held it in 20 quarters since.
  • 601 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Powell Investment Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.